Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleINTERVENTIONAL

Hydroxyapatite Ceramics As a Particulate Embolic Material: Report of the Clinical Experience

Michiya Kubo, Naoya Kuwayama, Yutaka Hirashima, Akira Takaku, Tetsuro Ogawa and Shunro Endo
American Journal of Neuroradiology September 2003, 24 (8) 1545-1547;
Michiya Kubo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Kuwayama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaka Hirashima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Takaku
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuro Ogawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shunro Endo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Our newly developed biocompatible embolic materials, hydroxyapatite ceramic microparticles, have good visibility during injection control and were shown to be capable of producing effective occlusion of the distal arteriocapillary bed in an experimental animal study. The purpose of this present study was to evaluate hydroxyapatite ceramic microparticles for use in human meningioma embolization.

METHODS: Thirteen patients with meningiomas underwent preoperative superselective embolization with the use of hydroxyapatite microparticles. Radiologic and histopathologic studies of the surgical specimens were performed.

RESULTS: During embolization, no microcatheter clogging was observed and angiographic devascularization was consistently obtained without unexpected proximal occlusions. Histopathologic findings showed that there was mild inflammatory response in the thrombosed lumen.

CONCLUSION: Hydroxyapatite microparticles are excellent embolic materials for the treatment of human meningioma. They have excellent biocompatibility and good injection control, which produces occlusion of the distal arteriocapillary bed.

Preoperative embolization of meningiomas was initially reported by Manelfe et al in 1973 (1) and has come to be a widely recognized preoperative procedure aimed at devascularization and obliteration of the arteriocapillary beds (2–5). In our preliminary study, we evaluated the characteristics and embolic properties of hydroxyapatite microparticles, both angiographically and histopathologically, in experimental animal embolization. Hydroxyapatite microparticles proved to be an effective and safe embolic material. The present clinical study was undertaken to evaluate these hydroxyapatite microparticles, both angiographically and histopathologically, in patients with meningiomas.

Methods

All the procedures were performed after approval of the Committee on Medical Ethics of Toyama Medical and Pharmaceutical University and after informed consent was obtained from the patients and/or their next of kin. Thirteen patients (six female, seven male; mean age, 56.5 years; age range, 35–73 years) with meningiomas at various locations (convexity, n = 6; sphenoid ridge, n = 3; parasagittal, n = 3; falx, n = 1) were enrolled in our study. Pre-embolization MR imaging and superselective cerebral angiography were performed for all patients. Hydroxyapatite microparticles (produced at 800°C), ranging between 100 and 250 μm in diameter, were sterilized by ethylene oxide gas during 24 hr before use. The suspension of hydroxyapatite was made in concentration, with 10 mg for 10 mL of 80% contrast media before injection. Microcatheters with transparent hubs were selected so that injection control of embolic materials could be visually monitored to prevent clogging of microcatheters. The transfemoral approach was used in all patients along with heparinization and local anesthesia. Diagnostic superselective angiography was performed immediately before embolization. Embolization was performed only in external carotid system feeders for preoperative purposes, and it was not performed in internal carotid artery feeders. After superselective catheterization of external carotid artery feeders, provocative testing with lidocaine and thiopental sodium was performed to check whether these arteries supplied any cranial nerves anastomosed to the ophthalmic arteries or cerebral arteries. Embolization was performed manually under fluoroscopic monitoring only for feeders that had negative results of provocative testing. Injection was discontinued when stagnation of flow was encountered.

After embolization, devascularization effect in each feeder was classified into two groups: group A (95%–100%) and group B (<95%). Patency of cannulated feeding arteries was checked angiographically immediately after embolization to detect proximal feeding arterial occlusion due to particle aggregation. Evaluation was performed by two neurosurgeons who were blinded to this study. In several feeders with positive results of the provocative testing, we used microcoils to obtain proximal occlusion; these vessels were not included in this study. The interval between embolization and surgery varied from 2 to 22 days (mean, 7.3 days). All the patients underwent surgery while under general anesthesia. After total or subtotal tumor removal, the sections of surgical specimens were examined with hematoxylin and eosin staining after incomplete decalcification.

Results

Embolization with hydroxyapatite microparticles was successfully performed in all 13 cases, for a total of 27 feeding arteries in meningiomas in various locations with no resulting general, focal, or neurologic complications. We experienced no microcatheter clogging during the embolization procedures. Microparticle injection was consistently easy. Control of injection was excellent because of the good visibility of the embolic agent, especially at the level of microcatheter hub. Tumor vascularity during the arterial to capillary phase was consistently noted to gradually decrease and finally disappear in all cases, so that tumor stain was not present during the venous phase. The devascularization grade of the vessels treated was A in all cases (Table). Unexpected feeder occlusion did not occur in any cases, and all the feeders were patent immediately after embolization, consistent with effective delivery of particles to the tumor arteriocapillary beds.

View this table:
  • View inline
  • View popup

Summary of 13 patients with meningioma embolized with hydroxyapatite microparticles

All 13 patients underwent total or subtotal tumor surgical removal. Histologic evaluation of incompletely decalcified specimens disclosed mild inflammatory response and lymphocytic infiltration in the perivascular spaces (Fig 1). No hemorrhage or angionecrosis was found in any of the specimens.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Hydroxyapatite microparticles (arrow) are seen in small arteries in meningioma with mild inflammatory response and lymphocytic infiltration in the perivascular spaces (hematoxylin and eosin; original magnification, ×100).

Discussion

Radiologic evidence of diffuse embolization consists of two findings: the first is complete devascularization of the tumor on angiograms, and the second is complete patency of the feeders immediately after devascularization of the tumor, consistent with obliteration of the distal arteriocapillary bed without unexpected proximal occlusion of feeders. From this standpoint, our material showed satisfactory results (Fig 2A and B). Recent advancements in microcatheter and microwire technology and digital subtraction angiography enabled us to perform tumor embolization much easier and safer than before. Appropriate selection of the cases, provocative testing before embolization, and careful use of embolic agents have also helped to reduce complications. However, several reports of recanalization after embolization have been published (4, 6), as have reports of complications of unclear cause, some of which may be related to the characteristics of the embolic materials themselves (6–8), such as intratumoral or peritumoral hemorrhage around the occluded vessels (9–11), edema around the occluded vessels (10), and AVF.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Superselective angiograms of the middle meningeal artery feeding a frontal parasagittal meningioma.

A, Before embolization.

B, Immediately after embolization with hydroxyapatite microparticles. The meningioma is angiographically devascularized.

An advanced inflammatory response is considered to cause arterial necrosis and hemorrhage. Subcutaneous tissue implantation is said to be more sensitive for detecting inflammation reaction to embolic materials than implantation in other organs, especially the brain (12–14). Misiek et al (15) showed a very mild inflammatory response with hydroxyapatite particles in subcutaneous tissue, but polyvinyl alcohol particles caused extensive fibrosis in subcutaneous tissue (16). In this regard, hydroxyapatite produces milder inflammation than does polyvinyl alcohol particles. On the other hand, early recanalization sometimes results from much less or almost no inflammatory response.

We experienced no hemorrhage or recanalization during a follow-up period of ≤24 weeks after embolization with our particles in our preliminary animal study. In the histopathologic section of resected meningiomas, hemorrhage and angionecrosis were not shown and expected mild inflammatory signs were shown, as were those of our animal experimental study. The ideal benign inflammation reaction may be obtained with hydroxyapatite particles.

More recently, it has been suggested that hydroxyapatite ceramics in a porous configuration be used as a drug or antibody release system, which is another unique characteristic of hydroxyapatite (7). These microparticles may even have a potential use as chemotherapeutic embolic material in the future.

Conclusion

In conclusion, hydroxyapatite ceramic microparticles constitute an excellent biocompatible embolic material with good visibility during injection control. They are capable of producing effective occlusion of distal arteriocapillary beds, with a resulting mild benign inflammatory response and preservation of the arterial feeders.

References

  1. ↵
    Manelfe C, Guiraud B, David J. Embolization by catheterization of intracranial meningiomas [in French]. Rev Neurol Paris 1973;128:339–351
    PubMed
  2. ↵
    Richter HP, Schachenmayr W. Preoperative embolization of intracranial meningiomas. Neurosurgery 1983;13:261–268
    PubMed
  3. Castaneda-Zuniga WR, Sanchez R, Amplatz K. Experimental observations on short and long-term effects of arterial occlusion with Ivalon. Radiology 1978;126:783–785
    CrossRefPubMed
  4. ↵
    Teasdale E, Patterson J, McLellan D, Mcpherson P. Subselective preoperative embolization for meningiomas: a radiological and pathological assessment. J Neurosurg 1984;60:506–511
    PubMed
  5. ↵
    Manelfe C, Lasjaunias P, Ruscalleda J. Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol 1986;7:963–972
    Abstract/FREE Full Text
  6. ↵
    Kurata A, Saegusa H, Ohmomo T, et al. Preoperative embolization for meningiomas using PVA particles [in Japanese]. No Shinkei Geka 1992;20:367–373
    PubMed
  7. ↵
    Netz DJ, Sepulveda P, Pandolfelli VC, et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm 2001;213:117–125
    CrossRefPubMed
  8. ↵
    Wakhloo AK, Juengling FD, Van Velthoven V, et al. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR Am J Neuroradiol 1993;14:571–582
    Abstract/FREE Full Text
  9. ↵
    Turjman F, Massoud TF, Vinters HV, et al. Collagen microbeads: experimental evaluation of an embolic agent in a rete mirabile of the swine. Am J Neuroradiol 1995;16:1031–1036
    Abstract
  10. ↵
    Dion JE, Rankin RN, Viñuela F, Fox AJ, Wallace AC, Mervart M. Dextran microsphere embolization: experimental and clinical experience with radiologic-pathologic correlation: work in progress. Radiology 1986;160:717–721
    PubMed
  11. ↵
    Purdy PD, Samson D, Batjer HH, Risser RC. Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: experience in 51 adults. AJNR Am J Neuroradiol 1990;11:501–510
    Abstract/FREE Full Text
  12. ↵
    Sadato A, Taki W, Ikada Y, et al. Experimental study and clinical use of poly(vinyl acetate) emulsion as liquid embolisation material. Neuroradiology 1994;36:634–641
    CrossRefPubMed
  13. Schweitzer JS, Chang BS, Madsen P, et al. The pathology of arteriovenous malformations of the brain treated by embolotherapy: II. results of embolization with multiple agents. Neuroradiology 1993;35:468–474
    CrossRefPubMed
  14. ↵
    Lanman TH, Martin NA, Vinters HV. The pathology of encephalic arteriovenous malformations treated by prior embolotherapy. Neuroradiology 1988;30:1–10
    CrossRefPubMed
  15. ↵
    Misiek DJ, Kent JN, Carr RF. Soft tissue responses to hydroxyapatite particles of different shapes. J Oral Maxillofac Surg 1984;42:150–160
    PubMed
  16. ↵
    Chen RW, Musser AW, Postlethwait RW. Alterations of and tissue reaction to polyvinyl alcohol sponge implants. Surgery 1969;66:899–906
    PubMed
  • Received March 25, 2002.
  • Accepted after revision April 4, 2003.
  • Copyright © American Society of Neuroradiology
Back to top

In this issue

American Journal of Neuroradiology: 24 (8)
American Journal of Neuroradiology
Vol. 24, Issue 8
1 Sep 2003
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxyapatite Ceramics As a Particulate Embolic Material: Report of the Clinical Experience
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Michiya Kubo, Naoya Kuwayama, Yutaka Hirashima, Akira Takaku, Tetsuro Ogawa, Shunro Endo
Hydroxyapatite Ceramics As a Particulate Embolic Material: Report of the Clinical Experience
American Journal of Neuroradiology Sep 2003, 24 (8) 1545-1547;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Hydroxyapatite Ceramics As a Particulate Embolic Material: Report of the Clinical Experience
Michiya Kubo, Naoya Kuwayama, Yutaka Hirashima, Akira Takaku, Tetsuro Ogawa, Shunro Endo
American Journal of Neuroradiology Sep 2003, 24 (8) 1545-1547;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Advanced Chemoembolization by Anti-angiogenic Calcium-Phosphate Ceramic Microspheres Targeting the Vascular Heterogeneity of Cancer Xenografts
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • SAVE vs. Solumbra Techniques for Thrombectomy
  • CT Perfusion&Reperfusion in Acute Ischemic Stroke
  • Delayed Reperfusion Post-Thrombectomy&Thrombolysis
Show more Interventional

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire